Penobscot Investment Management Company Inc. increased its position in shares of Aetna Inc. (NYSE:AET) by 2.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,400 shares of the company’s stock after buying an additional 250 shares during the period. Penobscot Investment Management Company Inc.’s holdings in Aetna were worth $1,731,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AET. Nationwide Fund Advisors increased its position in Aetna by 71.4% in the first quarter. Nationwide Fund Advisors now owns 207,098 shares of the company’s stock worth $26,415,000 after buying an additional 86,247 shares during the period. CAPROCK Group Inc. increased its position in Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares during the period. Focused Investors LLC increased its position in Aetna by 21.6% in the first quarter. Focused Investors LLC now owns 863,600 shares of the company’s stock worth $110,152,000 after buying an additional 153,600 shares during the period. State of Alaska Department of Revenue bought a new position in Aetna during the first quarter worth approximately $1,060,000. Finally, Rothschild Investment Corp IL bought a new position in Aetna during the first quarter worth approximately $225,000. Hedge funds and other institutional investors own 91.69% of the company’s stock.

Shares of Aetna Inc. (NYSE AET) opened at 155.81 on Friday. Aetna Inc. has a 12 month low of $104.59 and a 12 month high of $161.69. The company has a market capitalization of $51.74 billion, a P/E ratio of 34.59 and a beta of 0.54. The company has a 50-day moving average of $154.74 and a 200 day moving average of $140.10.

Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the previous year, the company earned $2.21 EPS. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. Analysts forecast that Aetna Inc. will post $9.55 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2017/08/18/aetna-inc-aet-shares-bought-by-penobscot-investment-management-company-inc.html.

A number of research firms have commented on AET. Royal Bank Of Canada increased their price objective on shares of Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a research note on Friday, August 4th. Jefferies Group LLC reiterated a “hold” rating and set a $163.00 price objective (up from $157.00) on shares of Aetna in a research note on Friday, August 4th. Deutsche Bank AG increased their price objective on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Cantor Fitzgerald reiterated an “overweight” rating and set a $175.00 price objective (up from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Finally, Morgan Stanley increased their price objective on shares of Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a research note on Thursday. Seven equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $157.99.

In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total value of $4,033,388.44. Following the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,008,606.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.90% of the stock is currently owned by insiders.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.